KEMIA
0555.976.383 · rovalta.com · 24/09/2026
ACTIVE
KEMIA
Financial year 2025 · Closed on 31/12/2025
Net result
1,3 M €
+60,3 %over 1 yearRevenue
279,3 k €
-1,5 %over 1 yearEquity
8,2 M €
+18,3 %over 1 yearOverview
Identity
Source · BCE/KBOKEMIA is a Private limited company incorporated in 2014. Its registered office is in Hoogstraten.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0555.976.383
- Incorporation
- 14/07/2014
- Legal form
- Private limited company
- Registered office
- Witherenweg 54
2322 Hoogstraten · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 279,3 k € | -1.5% | 283,6 k € | +2.5% | 276,5 k € | +14.9% | 240,7 k € | – | |
| EBITDA | 147,7 k € | -2.6% | 151,7 k € | -12.4% | 173,2 k € | +63.7% | 105,8 k € | -18.0% | 129 k € |
| Operating result | 130,3 k € | -2.7% | 133,8 k € | -13.7% | 155,1 k € | +76.9% | 87,7 k € | -28.3% | 122,4 k € |
| Net result | 1,3 M € | +60.3% | 794,2 k € | +50.6% | 527,5 k € | +9.3% | 482,8 k € | -20.4% | 606,3 k € |
| Balance sheet | |||||||||
| Equity | 8,2 M € | +18.3% | 7 M € | +11.6% | 6,2 M € | +9.0% | 5,7 M € | +7.2% | 5,3 M € |
| Total assets | 8,9 M € | +14.8% | 7,7 M € | +2.5% | 7,6 M € | +5.5% | 7,2 M € | +3.1% | 6,9 M € |
| Cash | 1,2 M € | +2108% | 54,5 k € | -91.3% | 627,1 k € | +168% | 234,4 k € | +57.9% | 148,4 k € |
| Debts | 654,3 k € | -16.0% | 778,5 k € | -40.7% | 1,3 M € | -8.6% | 1,4 M € | -10.3% | 1,6 M € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Jan Embrechts
ActiveEnded mandates
Jan Embrechts
EndedOther companies at this address
Witherenweg 54 2322 Hoogstraten| Company | CBE no. |
|---|---|
Calluna Pharma● Active | 0866.397.070 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/06/2026 | 24/06/2025 | 18/06/2024 | 03/07/2023 | 30/06/2022 | 16/06/2021 |
| General meeting | 02/06/2026 | 03/06/2025 | 04/06/2024 | 06/06/2023 | 07/06/2022 | 05/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 02/06/2026 | 22/06/2026 | Dutch | |
| Full model | 31/12/2024 | 03/06/2025 | 24/06/2025 | Dutch | |
| Full model | 31/12/2023 | 04/06/2024 | 18/06/2024 | Dutch | |
| Full model | 31/12/2022 | 06/06/2023 | 03/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 07/06/2022 | 30/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 05/06/2021 | 16/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 05/06/2020 | 25/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 07/06/2019 | 11/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 01/06/2018 | 22/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 02/06/2017 | 06/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 03/06/2016 | 30/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 05/06/2015 | 16/06/2015 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Jan Embrechts
ActiveEnded mandates
Jan Embrechts
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,3 M €↑
- 2024Annual accounts 2024794,2 k €↑
- 2023Annual accounts 2023527,5 k €↑
- 2022Annual accounts 2022482,8 k €↓
- 2021Annual accounts 2021606,3 k €↓
- 2020Annual accounts 20201,3 M €↑
- 2019Annual accounts 20191,1 M €↑
- 2018Annual accounts 201810,4 k €↓
- 2017Annual accounts 201716 k €↓
- 2016Annual accounts 20162,5 M €↑
- 2015Annual accounts 2015-159,4 k €↓
- 2014Annual accounts 2014-23,5 k €
- 14/07/2014IncorporationPrivate limited company